Geri Dön

Deneysel nonalkolik steatohepatit modelinde genisteinin koruyucu rolü

Preventive role of genistein in experimental non-alcoholic steatohepatitis model

PDF İndir

  1. Tez No: 193946
  2. Yazar: MEHMET YALNIZ
  3. Danışmanlar: PROF.DR. İBRAHİM HALİL BAHCECİOĞLU
  4. Tez Türü: Tıpta Uzmanlık
  5. Konular: Gastroenteroloji, Gastroenterology
  6. Anahtar Kelimeler: 1RQDONROLN VWHDWRKHSDWLW \D÷GDQ ]HQJLQ GL\HW RNVLGDWLI VWUHVgenistein, Nonalcoholic steatohepatitis, high fat diet, oxidative stress, genistein
  7. Yıl: 2005
  8. Dil: Türkçe
  9. Üniversite: Fırat Üniversitesi
  10. Enstitü: Tıp Fakültesi
  11. Ana Bilim Dalı: İç Hastalıkları Ana Bilim Dalı
  12. Bilim Dalı: Belirtilmemiş.
  13. Sayfa Sayısı: Belirtilmemiş.

Özet

1. ÖZETOksidatif stres nonalkolik steatohepatit (NASH) patogenezinde rol alan enönemli faktörlerden biridir. Birçok farmakolojik özelliklere sahip bir fitoöstrojenolan genisteinin (4',5, 7-trihydoxyisoflavone) antioksidan ve anti-inflammatuvarHWNLOHUL ROGX÷X ELOLQPHNWHGLU %X oDOÕúPDGD GHQH\VHO RODUDN ROXúWXUXODQ 1$6+PRGHOLQGHJHQLVWHLQLQNRUX\XFXUROQDUDúWÕUGÕN48 adet erkek Sprague-Dawley rat randomize olarak dört HúLW JUXED D\UÕOGÕ%LULQFLJUXSVDGHFHVWDQGDUWUDW \HPLDOGÕNRQWUROJUXEXJUXS.*UXSSODVHERVHUXPIL]\RORMLNJUXEXJUXSYH¶HLVH\D÷GDQ]HQJLQGL\HW<='DGOLELWXPRODUDNYHULOGL*UXS¶H<='¶HEDúODPDGDQELUJQ|QFHYHWPGHQH\süresince 0.2PJNJJQ GR]XQGD JHQLVWHLQ VXENXWDQ RODUDN X\JXODQGÕ JHQLVWHLQ NRUX\XFX *.grup). Grup 4'e dördüncü haftadan sonra iki hafta 0.2 mg/kg/gün dozunda genisteinVXENXWDQRODUDNX\JXODQGÕJHQLVWHLQWHGDYL*7JUXEXKDIWDELWWLNWHQVRQUDtümUDWODU |OGUOG .DQ |UQHNOHUL YH NDUDFL÷HU GRNXODUÕ DOÕQGÕ $PLQRWUDQVIHUD]ODUSOD]PDYHNDUDFL÷HUPDORQGLDOGHKLG0'$G]H\OHUL|OoOG+LVWRSDWRORMLNRODUDNNDUDFL÷HUGHVWHDWR]EDORQODúPDGHMHQHUDV\RQXLQIODPPDV\RQ0DOORU\FLVLPFL÷LYHfibro]LVGH÷HUOHQGLULOGL$67 YH $/7 GH÷HUOHUL S SOD]PD YH NDUDFL÷HU 0'$ YH SOD]PDTNF-DOID G]H\OHUL S VÕUDVÕ LOH SODVHER JUXEXQGD NRQWUROgrubundan yüksekti. TGF-EHWD G]H\OHULQGH DQODPOÕ IDUN \RNWX +LVWRSDWRORMLNolarak steatoz, mm2 GHNL RUWDODPD LQIODPDWXYDU KFUH VD\ÕVÕ YH EDORQODúPDGHMHQHUDV\RQX SODVHER JUXEXQGD NRQWURO JUXEXQD J|UH DQODPOÕ RODUDN \NVHNWL SKHSVLQGH )LEUR]LV YH 0DOORU\ FLVPL VDSWDQPDGÕ +HP *. KHP GH *7grubunda AST ve ALT düzeyleri (p hepsinGH SOD]PD YH NDUDFL÷HU 0'$düzeyleri ve TNF-DOID G]H\OHUL SODVHER JUXEXQD J|UH DQODPOÕ RODUDN GúNW SKHSVLQGH+LVWRSDWRORMLNLQFHOHPHGH*.YH*7JUXSODUÕQGDVWHDWR]VÕUDVÕLOHp<0.05 ve <0.01), mm2 deki ortalama inflamatuvar hücre sayÕVÕ KHU LNL JUXSWDS YH EDORQODúPD GHMHQHUDV\RQX KHU LNL JUXSWD SODVHER JUXEXQD J|UHDQODPOÕRODUDNGúNWSonuç: *oO ELU DQWLRNVLGDQ RODQ JHQLVWHLQ GHQH\VHO RODUDN 1$6+ JHOLúLPLQLbelirgin olarak önlemekte, histopatolojik ve biyokimyasal düzelme ile steatohepatitiD]DOWPDNWDGÕU

Özet (Çeviri)

Oxidative stress is one of the important factors that are playing role in thepathogenesis of nonalcoholic steatohepatitis (NASH). Genistein (4?,5, 7-trihydoxyisoflavone), a phytoestrogen with several pharmacological features, hasalso antioxidant and anti-inflammatuar properties. In the present study, we evaluatedpreventive role of genistein in NASH model induced experimentally.48 Sprague-Dawley rats were divided into four equal groups randomly. Firstgroup received only standart rat chow diet (control group: grup C). Group 2 (groupplacebo), 3 and 4 were given high fat diet (HFD) ad libitum. 0.5 ml serumphysiologic injected daily to placebo group subcutaneously. 0.2 mg/kg/day genisteininjected subcutaneously to group 3 (genistein prevention (GP) group) starting oneday before HFD administration and during the whole experiment. After the fourthweek, genistein at 0.2 mg/kg/day injected subcutaneously to the fourth group(genistein treatment (GT) group). All rats killed after six weeks. Blood samplescollected and tissue samples prepared. Aminotransferases, plasma and livermalondialdehyde (MDA) levels were measured. Steatosis, ballooning degeneration,inflammation, Mallory body and fibrosis in the liver examined histopathologically.AST and ALT levels (p for each <0.001), plasma and liver tissue MDA andplasma TNF-alpha levels (p <0.001, <0.001, <0.01, respectively) were higher inplacebo group than in the control group. TGF-beta levels were comparable in theplacebo and control groups. In histopthological examination, steatosis, inflammatuarcells per mm2 and balloning degeneration were significantly higher in the placebogroup than in the control group (p for each <0.001). There was no fibrosis andMallory body. AST and ALT levels (p for each <0.05), plasma and liver tissueMDA and plasma TNF-alpha levels were significantly lower (p <0.05 for each)either in GP or in GT groups compared to the placebo group. Histopathologically,steatosis (p<0.05 and <0.01 respectively), mean number of inflammatuar cells permm2 (p<0.01 for each) and balloning degeneration (p <0.01 for each) in GP and GTgroups were significantly lower than in the placebo group.In conclusion; genistein, a strong antioxidant agent, not only remarkablyprevents the emergence of NASH, but also attenuates the existing steatohepatitis byimproving the biochemical and histopathological abnormalities.

Benzer Tezler

  1. Tez No

    625000

    Deneysel nonalkolik steatohepatit modelinde kolsişinin karaciğer üzerine etkisinin incelenmesi

    Investigation of colchicine effects on liver in experimental nonalcoholic steatohepatitis model

    FATMA F.MOHAMED AMRAJE

    Doktora

    Türkçe

    Türkçe

    2020

    Histoloji ve EmbriyolojiGazi Üniversitesi

    Histoloji ve Embriyoloji Ana Bilim Dalı

    PROF. DR. SUNA ÖMEROĞLU

  2. Tez No

    267841

    Alkol dışı yağlı karaciğer hastalığında karaciğerde cox-2 ekspresyonunun immünhistokimyasal olarak incelenmesi ve histopatolojik bulgularla ilişkisinin araştırılması

    Expression of cyclooxygenase-2 and it's pathogenic effects in nonalcoholic fatty liver disease

    BURCU ÜLKÜDEN

    Tıpta Uzmanlık

    Türkçe

    Türkçe

    2010

    GastroenterolojiEge Üniversitesi

    İç Hastalıkları Ana Bilim Dalı

    PROF. DR. ULUS SALİH AKARCA

  3. Tez No

    165012

    Deneysel non alkolik steatohepatit modelinde anti TNF alfanın etkisi

    Effect of anti TNF alpha in experimental model of non alcoholic steatohepatits

    SÜLEYMAN SERDAR KOCA

    Tıpta Uzmanlık

    Türkçe

    Türkçe

    2005

    GastroenterolojiFırat Üniversitesi

    İç Hastalıkları Ana Bilim Dalı

    DOÇ.DR. İBRAHİM HALİL BAHÇECİOĞLU

  4. Tez No

    366038

    Fruktozla oluşturulan nonalkolik yağlı karaciğer modelinde rifaksimin'in önleyici rolü

    The protective role of rifaximin in non alcoholic fatty liver disease created with fructose

    NEŞE ÇABUK ÇELİK

    Tıpta Uzmanlık

    Türkçe

    Türkçe

    2014

    GastroenterolojiFırat Üniversitesi

    Dahili Tıp Bilimleri Bölümü

    PROF. DR. İBRAHİM HALİL BAHÇECİOĞLU

  5. Tez No

    153844

    Roziglitazonun sıçanlarda metionin ve kolinden yoksun diyetle geliştirilen non-alkolik steatohepatit modeli üzerine etkisi

    The effect of rosiglitazone on methionine and choline deficient diet model of non-alcoholic steatohepatits on rats

    VEYSEL TAHAN

    Tıpta Yan Dal Uzmanlık

    Türkçe

    Türkçe

    2006

    GastroenterolojiMarmara Üniversitesi

    İç Hastalıkları Ana Bilim Dalı

    PROF. DR. NURDAN TÖZÜN

Geri Dön